Skip to main content
Biovica International AB (publ) (STO:BIOVIC.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.313
-0.007 (-2.19%)
Apr 29, 2026, 2:36 PM CET

Biovica International AB Revenue

Biovica International AB had revenue of 3.29M SEK in the quarter ending January 31, 2026, with 45.69% growth. This brings the company's revenue in the last twelve months to 10.93M, up 33.38% year-over-year. In the fiscal year ending April 30, 2025, Biovica International AB had annual revenue of 8.65M with 18.53% growth.

Revenue (ttm)
10.93M
Revenue Growth
+33.38%
P/S Ratio
8.55
Revenue / Employee
455.21K
Employees
24
Market Cap
93.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Apr 30, 20258.65M1.35M18.53%
Apr 30, 20247.30M2.08M39.99%
Apr 30, 20235.21M113.00K2.22%
Apr 30, 20225.10M-2.38M-31.84%
Apr 30, 20217.48M-2.20M-22.71%
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Magle Chemoswed Holding AB 287.55M
Scandinavian ChemoTech AB 12.29M
AcouSort AB 10.43M
OncoZenge AB 2.78M
Simris Group AB (PUBL) 1.62M
Spago Nanomedical AB 4.82M
Pila Pharma AB 1.13M
Nanologica AB 21.13M
Revenue Rankings

Biovica International AB News

More News